Synthetic peptides coupled to the lipotripeptide P3CSS induce in vivo B and Thelper cell responses to HIV-1 reverse transcriptase

Immunobiology

Volumn 195, Issue 1, 1996, Pages 61-76

  Loleit, Manuel ^a   Ihlenfeldt, Hans Georg ^b   Brünjes, Jente ^b   Jung, Günther ^b   Müller, Bernd ^a   Hoffmann, Petra ^a   Bessler, Wolfgang G ^a   Pierres, Michel ^c   Haas, Gaby ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LIPOPEPTIDE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030020566     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80006-4     Document Type: Article

References (37)

1. BROWN, F., R. H. CHANOCK, H. S. GINOBERG, and R. A. LERNER. 1990. Vaccines 90, Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbour Laboratory Press, New York.
2. + lymphocytes. Eur. J. Immunol. 21: 1371.
3. FERNS, R. B., J. C. PARTRIDGE, M. TISDALE, N. HUNT, and R. S. TEDDER. 1991. Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene products. AIDS Res. Hum. Retrov. 7: 307.
4. TISDALE, M., P. ERTL, B. A. LARDER, D. J. M. PURIFOY, G. DARBY, and K L. POWELL. 1988. Characterisation of human immunodeficiency virus type I reverse transcriptase by using monoclonal antibodies; role of the C-terminus in antibody reactivity and enzyme function. J. Virol. 62: 3662.
5. MYERS, G., B. KORBER, J. A. BERZOFSKY, R. F. SMITH, and G. N. PAVLAKIS. 1992. Human retroviruses and AIDS. Los Alamos National Laboratories, Los Alamos.
6. HOPP, T. P. 1984. Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier. Mol. Immunol. 31: 13.
7. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOM's. Nature 344: 873.
8. + cytotoxic T lymphocytes. J. Exp. Med. 176: 1739.
9. BESSLER, W. G., and G. JUNG. 1992. Synthetic lipopeptides as novel adjuvants. Res. Immunol. 143: 475.
10. METZGER, J., K. H. WIESMULLER, R. SCHAUDE, W. G. BESSLER, and G. JUNG. 1991. Synthesis of novel immunologicaily active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Int. J. Peptide Protein Res. 37: 46.
11. LOLEIT, M., W. TRÖGER, K. H. WIESMULLER, G. JUNG, M. STRECKER, and W. G. BESSLER. 1990. Conjugates of synthetic lymphocyte-activating lipopeptides with segments from HIV proteins induce protein-specific antibody formation. Biol. Chem. Hoppe-Seyler 371: 967.
12. DERES, K., H. SCHILD, K. H. WIESMULLER, G. JUNG, and H.-G. RAMMENSEE. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342: 561.
13. JUNG, G., and A. G. BECK-SICKINGER. 1992. Multiple peptide synthesis methods and their application. Angew. Chem. Int. Ed. eng. 31: 367.
14. HOFFMANN, P., K. H. WIESMULLER, J. METZGER, G. JUNG, and W. G. BESSLER. 1989. Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues. Biol. Chem. Hoppe-Seyler 370: 575.
15. SLOAN-LANCASTER, J., B. D. EVAVOLD, and P. M. ALLEN. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363: 156.
16. 1. J. Immunol. 130: 637.
17. HOSMALIN, A., P. L. NARA, M. ZWEIG, N. W. LERCHE, K. B. CEASE, E. A. GARD, P D. MARKHAM, S. D. PUTNEY, M. D. DANIEL, R. C. DESROSIERS, and J. A. BERZOFSKY. 1991. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates. J. Immunol. 146: 1667.
18. PEARSON, W. R. 1990. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183: 63.
19. STADEN, R. 1990. Searching for patterns in protein and nucleic acid sequences. Methods Enzymol. 183: 193.
20. + T cell epitopes: A peptide-based multiparametric assessment in mice. Eur. J. Immunol. 24: 1496.
21. MARTINON, F., H. GRAS-MASSE, C. BOUTILLON, F. CHIRAT, B. DEPREZ, J.-G. GUILLET, E. GOMARD, A. TARTAR, and J.-P. LEVY. 1992. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. J. Immunol. 149: 3416.
22. DEFOORT, J.-P., B. NARDELLI, W. HUANG, D. D. Ho, and J. P. TAM. 1992. Macromolecular assembling in the design of a synthetic AIDS vaccine. Proc. Natl. Acad. Sci. USA 89: 3879.
23. WIESMULLER, K. H., W. G. BESSLER, and G. JUNG. 1992. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope specific B-, T-helper and T-killer cell response. Int. J. Peptide Protein Res. 40: 255.
24. PADBERG, C., S. NOLAN, and B. MERMER. 1989. Recombinant peptides from human immunodeficiency virus reverse transcriptase define three epitopes recognized by antibodies in sera from patients with acquired immunodeficiency syndrome. AIDS Res. Hum. Retrov. 5: 63.
25. TAHTINEN, M., F. GOMBERT, E.-R. HYTINEN, G. JUNG, A. RANKI, and K. J. E. KROHN. 1992. Fine specificity of the B cell epitopes recognized in HIV nef by human sera. Virology 187: 156.
26. SZILVAY, A. M., S. NORNES, I. R. HAUGAN, L. OLSENN, V. R. PRASAD, C. ENDRESEN, S. P. GOFF, and D. E. HELLAND. 1992. Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNase activities. J. AIDS 5: 647.
27. BJORLING, E., G. UTTER, P. STALHANSKE, E. NORBY, and F. CHIODI. 1991. Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein. J. Virol. 65: 4543.
28. + lymphocyte counts: immunologic and virologic characteristics. Infect. Dis. 163: 959.
29. MCDOUGAL, J. S., M. S. KENNEDY, J. K. A. NICHOLSON, T. J. SPIRA, H. W. JAFFE, J. E. KAPLAN, D. B. FISHBEIN, P. O'MALLEY, C. H. ALOISIO, C. M. BLACK, M. HUBBARD, and C. B. REIMER. 1987. Antibody response to human immunodeficiency virus in homosexual men: relation of antibody specificity, titer, isotype to clinical status, severity of immunodeficiency, and disease progression. J. Clin. Invest. 80: 316.
30. BAUR, A., R. VORNHAGEN, K. KORN, H. H. SONNEBORN, B. EBERLEIN, T. HARRER, W. BROCKHAUS, and G. JAHN. 1992. Viral culture and p24 antigenemia of human immunodeficiency virus (HIV) infected individuals correlated with antibody profiles determined with recombinant polypeptide of all HIV-1 open-reading frames. Infect. Dis. 164: 419.
31. DEGROOT, A. S., M. CLERICI, A. HOSMALIN, S. H. HUGHES, D. BARND, C. W. HENDRIX, R. HOUGHTEN, G. M. SHEARER, and J. A. BERZOFSKY. 1991. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. J. Infect. Dis. 164: 1058.
32. HOSMALIN, A., M. CLERICI, B. HOUGHTEN, C. D. PENDELTOSN, C. FLEXNER, D. LUCEY, B. Moss, R. N. GERMAIN, G. M. SHEARER, and J. A. BERZOFSKY. 1990. An epitope in HIV-1 reverse transcriptase recognized by both mouse and human CTL. Proc. Natl. Acad. Sci. USA 87: 2344.
33. d. Science 256: 1817.
34. ROTHBARD, J. B., and W. R. TAYLOR. 1988. A sequence pattern common to T cell epitopes. Embo J. 7: 93.
35. URBAN, R. G., R. M. CHICZ, W. S. LANE, J. L. STROMINGER, A. REHM, M. J. H. KENTER, F. G. C. M. UYTDEHAAG, H. PLOEGH, B. UCHANSKA-ZIEGLER, and A. ZIEGLER. 1994. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. USA 91: 1534.
36. HOSMALIN, A., J. KUMAR, D. BARND, R. HOUGHTEN, G. E. SMITH, S. H. HUGHES, and J. A. BERZOFSKY. 1992. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from plasmodium falciparum and HIV-1. J. Immunol. 149: 1311.
37. HICKLING, J. K., C. M. FENTON, K. HOWLAND, S. G. E. MARSH, and J. B. ROTHBARD. 1990. Peptides recognized by class I restricted T cells also bind to MHC class II molecules. Int. Immunol. 2: 435.